Masimo | MASI - Stock


Masimo reported $338.6M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Abbott USD 6.49B 220M Dec/2025
Accuray USD 155.5M 14.48M Sep/2025
Align Technology USD 228.16M 15.59M Sep/2025
AngioDynamics USD 65.57M 3.56M Sep/2025
Artivion USD 92.43M 1.88M Dec/2025
AtriCure USD 78.49M 459K Dec/2025
Avanos Medical USD 148M 2.6M Dec/2025
Baxter International USD 2.23B 228M Dec/2025
Becton, Dickinson and Co. USD 4.08B 191M Dec/2025
Boston Scientific USD 2.94B 22M Dec/2025
Dexcom USD 629.1M 25M Dec/2025
Edwards Lifesciences USD 1.13B 14.7M Dec/2025
General Electric Aerospace USD 12.37B 499M Mar/2026
Globus Medical USD 759.28M 12.26M Dec/2025
Haemonetics USD 321.18M 15.02M Dec/2025
Inogen USD 25.08M 762K Sep/2025
Insulet USD 452.6M 6.3M Dec/2025
Integra LifeSciences USD 492.73M 3.63M Dec/2025
Intuitive Surgical USD 1.95B 105.1M Mar/2026
Masimo USD 338.6M 20.1M Sep/2025
Medtronic USD 6.31B 153M Dec/2025
Orthofix International USD 172.32M 1.72M Dec/2025
Owens Minor USD 74.44M 10.59M Dec/2025
ResMed USD 922.04M 23.76M Dec/2025
Steris USD 673.5M 15M Dec/2025
Stryker USD 5.31B 60M Dec/2025
Tandem Diabetes Care USD 128.77M 8.51M Dec/2025
Teleflex USD 802.46M 108.78M Sep/2025
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Zimmer Biomet Holdings USD 2.29B 197.3M Dec/2025